Molecular Partners AG
Patents, Design & Utilities
Last updated:
List of all Molecular Partners AG patents 13 in total
| Status | Patent |
|---|---|
Application | Utility: RECOMBINANT FAP BINDING PROTEINS AND THEIR USE Filling date: 6 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: NOVEL ANKYRIN REPEAT BINDING PROTEINS AND THEIR USES Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: RECOMBINANT PEPTIDE-MHC COMPLEX BINDING PROTEINS AND THEIR GENERATION AND USE Filling date: 6 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: DESIGNED ANKYRIN REPEAT DOMAINS WITH ALTERED SURFACE RESIDUES Filling date: 6 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: MULTISPECIFIC PROTEINS Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: NOVEL ANKYRIN REPEAT BINDING PROTEINS AND THEIR USES Filling date: 6 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: RECOMBINANT BINDING PROTEINS TARGETING HER2 AND SERUM ALBUMIN, AND THEIR USES Filling date: 6 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: MODIFIED BINDING PROTEINS INHIBITING THE VEGF-A RECEPTOR INTERACTION Filling date: 6 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: MULTISPECIFIC PROTEINS Filling date: 6 Sep 2025 Issue date: 10 Dec 2020 |
Grant | Utility: Recombinant binding proteins targeting HER2 and serum albumin, and their uses Filling date: 6 Sep 2025 Issue date: 21 Jul 2020 |
Grant | Utility: Modified binding proteins inhibiting the VEGF-A receptor interaction Filling date: 6 Sep 2025 Issue date: 12 May 2020 |
Application | Utility: RECOMBINANT BINDING PROTEINS AND THEIR USE Filling date: 6 Sep 2025 Issue date: 29 Aug 2019 |
Grant | Utility: Binding proteins comprising at least two repeat domains against HER2 Filling date: 6 Sep 2025 Issue date: 6 Aug 2019 |
Showing 1 to 13 of 13 patents.